Halipa, Jaharia .

HRN: 18-69-41  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2025
CEFUROXIME 1.5GM (VIAL)
12/03/2025
12/10/2025
IV
1.5g LD Then 750
Q8
Ltcs
Checking Final Appropriateness 

Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary TractIntra-abdominalReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: